Hard-Surface Probiotics Hospital Test

Microbial Cleaning for Biocontrol in Hospitals

disinfection protocols. This study aims to provide sufficient data to conclude whether the technique of biocontrol of hospital surfaces can act as a sustainable alternative to chemical disinfectants.

1.9 to 5.2 million patients. Similar incidences were measured in the United States [4]. Besides human suffering, also impressive economic costs are related to HAIs management. Indeed, as reported by the Centers for Disease Control and Prevention (CDC), it has been estimated that the overall annual direct medical costs for healthcare-associated infections in hospitals ranges from 35.7 to 45 billion dollars in the United States [5]. In addition, the management, prevention and monitoring of HAIs nowadays still represents a challenge for healthcare facilities [6,7]. The microorganisms most frequently isolated from HAIs are, in decreasing order, Escherichia coli (15.9%), Staphylococcus aureus (12.3%), Enterococcus spp. (9.6%), Pseudomonas aeruginosa (8.9%) Klebsiella spp. (8.7%), coagulase-negative staphylococci (7.5%), Candida spp. (6.1%), Clostridium difficile (5.4%), Entero- bacter spp. (4.2%), Proteus spp. (3.8%) and Acinetobacter spp. (3.6%) [3]. A very controversial and debated question is the qualitative and quantitative role of the environment in the patient contamination process, particularly the role of confinement and furnishing surfaces. It is well known that surfaces act as reservoirs for microorganisms and could contribute to the transmission of hospital pathogens, increasing the risk of cross-contamination through indirect contact with the patient [8–10]. To reduce such risks, sanitation procedures are applied to every surface that directly or indirectly may come in contact with people. Despite experimental evidence suggesting that a reasonable use of disinfectants is recommended, their routine use is still controversial [11,12]. Nevertheless, a proper surface disinfection is recom- mended by all international guidelines as an important procedure for preventing infections [13–17], and considerable evidence exist concerning the benefits of hospital cleanliness towards reducing HAIs [18]. Indeed, failure to ensure proper cleaning and sterilization or disinfection may lead to patient-to-patient trans- mission of pathogens [19]. However, the widespread use of chemical disinfectants presents risks towards the environment and the safety of personnel. It is clear that microorganisms can adapt to a variety of environmental physical and chemical conditions, and it is therefore not surprising that resistance to extensively used antiseptics and disinfectants has been reported [20,21]. For these reasons, the importance of cleaning procedures that are aimed to control the load of pathogenic bacteria indicates that a new and sustainable strategy is necessary. A very promising approach, as suggested by Falagas & Makris in 2009, is the use of non-pathogenic microorganisms, namely probiotics and defined as living microorganisms able to confer a health benefit on the host, to colonize hard surfaces in order to counteract the proliferation of other bacterial species [22], according to the competitive exclusion principle (Gause’s law) [23–25]. This concept has been designated as biocontrol when the application is antagonistic towards a certain pathogen [26], and has already successfully been applied to the abatement of Legionella in water systems [27]. Several investigators have pointed to evidence that probiotic type microorganisms and their biosurfactants may antagonize the growth of nosocomial pathogens on inanimate surfaces [28–32]. However, the actual application of probiotic type microorganisms on hard surfaces as a cleaning procedure has never been tested. Therefore, this study evaluates the effects of microbial cleaning of hard surfaces in hospitals on the presence and/or survival of HAI- related microorganisms on such treated surfaces. In order to facilitate the statistic meaningfulness of the results, the study was performed in three independent hospitals (one in Belgium and two in Italy). Comparison was made with chemical cleaning and

Methods Preliminary tests

Prior to the actual field trials in the hospitals, a number of preliminary tests were done at Ghent University, Ferrara University and AZ Lokeren hospital in order to determine the most suitable formulation of the microbial cleaning products to be used. Mainly the identity and concentration of the micro- organisms used in the cleaning products were chosen in view of the average microbiological load on hard surfaces, pH, temper- ature and humidity. The microbial cleaning products used in the field trials comprised spores of Bacillus subtilis , Bacillus pumilus and Bacillus megaterium , with a fixed quantity of 5 6 10 7 CFU per ml of product concentrate. All products were manufactured by Chrisal (Lommel, Belgium) and supplied to AZ Lokeren by Chrisal and the two Italian hospitals by Copma scrl. (Ferrara, Italy). In order to prevent bias in the eventual hospital trials due to the detergents in the products used, several field trials in the AZ Lokeren hospital were performed to compare the effect between the microbial and non-microbial version of the products to be used in the hospital trials (data not shown). Ethics Statement The study protocol was reviewed and approved by the local Ethics Committees. The trials in the two Hospitals residing in Ferrara (Sant’Anna and San Giorgio) were approved by the Ethics Committee, named Comitato Unico della Provincia di Ferrara (Unique Committee of the Ferrara Province), of the Azienda Ospedaliero-Universitaria of Ferrara (Ferrara, Italy). For the AZ Lokeren setting, the study was evaluated and approved by the AZ Lokeren Ethisch Comite ́ (Lokeren, Belgium). The two Ethics Committees stated that a formal authorization was not necessary because the probiotic products would not be directly administered to patients but exploited for cleaning of hospital surfaces only. For this reason, the Committees waived the need for written informed consent from participants because of the observational nature of the study. Hospital trial setup Three independent hospital trials, separated in time and location were performed. In each trial setting, comparison was made between cleaning with microbial cleaning products and the conventional hygiene protocols (using chemical cleaning products and disinfectants). Control cleaning products in AZ Lokeren consisted of chemical detergents (Ecolab, Groot-Bijgaarden, Belgium) and in both Italian hospitals chlorine based detergents (Actichlor for all washable surfaces, Diversey S.p.A., Italy) were applied. The microbial cleaning products in all three hospitals comprised a floor cleaner, interior cleaner and bathroom cleaner (Chrisal, Lommel, Belgium). Comparison between control and microbial cleaning was made both over time and on units with identical infrastructure within the hospital (e.g. two floors of geriatrics in AZ Lokeren). Except for the products, all other parameters related to the cleaning procedures (e.g. frequency, equipment) were the same between control and microbial cleaning. Cleaning in AZ Lokeren was performed according to the existing hygiene protocol of the hospital, and cleaning in the two Italian hospitals was performed according to the Probiotic Cleaning Hygiene System (PCHS) by Copma scrl. Cleaning staff

PLOS ONE | www.plosone.org


September 2014 | Volume 9 | Issue 9 | e108598

Made with FlippingBook - Online Brochure Maker